Isomorphic Labs Closes $5 Billion Series C With Alphabet's Backing
Isomorphic Labs, the drug discovery company spun out of Google DeepMind and backed by Alphabet, closed a $5 billion Series C round on November 17 and followed it with a cancer research deal signed with Merck two days later, a pairing that makes the company one of the best-capitalized players in AI…

